122 related articles for article (PubMed ID: 26908120)
1. [PREFERE - Study on the rise].
Ohlmann CH; Stöckle M; Albers P; Schmidberger H; Härter M; Kristiansen G; Martus P; Wellek S; Bussar-Maatz R; Wiegel T
Urologe A; 2016 Mar; 55(3):313-7. PubMed ID: 26908120
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO].
Rexer H; Bussar-Maatz R
Urologe A; 2015 May; 54(5):723-5. PubMed ID: 25802104
[No Abstract] [Full Text] [Related]
3. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
Abdollah F; Schmitges J; Sun M; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2012 Sep; 19(9):836-44. PubMed ID: 22574746
[TBL] [Abstract][Full Text] [Related]
5. [Clarification regarding criticism on PREFERE].
Stöckle M
Urologe A; 2015 Dec; 54(12):1792-4. PubMed ID: 26704281
[No Abstract] [Full Text] [Related]
6. [PREFERE--the German prostatic cancer study].
Porzsolt F
Urologe A; 2014 Mar; 53(3):388-9. PubMed ID: 23975217
[No Abstract] [Full Text] [Related]
7. [PREFERE--the German prostatic cancer study].
Weißbach L; Theuerkauf O
Urologe A; 2014 Mar; 53(3):387. PubMed ID: 23975216
[No Abstract] [Full Text] [Related]
8. [PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013].
Wiegel T; Albers P; Bussar-Maatz R; Gottberg A; Härter M; Kieser M; Kristiansen G; Nettekoven G; Martus P; Schmidberger H; Wellek S; Stöckle M
Urologe A; 2013 Apr; 52(4):576-9. PubMed ID: 23571802
[TBL] [Abstract][Full Text] [Related]
9. [Metastatic, hormone-naive prostate cancer interventional study : Multicenter, prospective, randomized study to evaluate the effect of standard drug therapy with or without radical prostatectomy in patients with limited bone metastasized prostate cancer (G-RAMPP - the AUO AP 75/13 study)].
Rexer H
Urologe A; 2015 Nov; 54(11):1613-6. PubMed ID: 26573673
[No Abstract] [Full Text] [Related]
10. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
[TBL] [Abstract][Full Text] [Related]
11. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
12. [No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression].
Garcia Schüler H; Guckenberger M
Strahlenther Onkol; 2017 Jan; 193(1):86-88. PubMed ID: 27904940
[No Abstract] [Full Text] [Related]
13. [Localised prostate cancer: the PREFERE trial].
Stöckle M; Bussar-Maatz R
Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):333-5; discussion 335. PubMed ID: 22818151
[TBL] [Abstract][Full Text] [Related]
14. First prostate cancer audit calls for wider use of modern imaging techniques.
Wise J
BMJ; 2014 Nov; 349():g6723. PubMed ID: 25385433
[No Abstract] [Full Text] [Related]
15. Radiation therapy after radical prostatectomy.
Ziada AM; Crawford ED
ScientificWorldJournal; 2004 Jun; 4 Suppl 1():377-81. PubMed ID: 15349561
[No Abstract] [Full Text] [Related]
16. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment to comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
Costantini E; Mearini L
Int J Urol; 2012 Sep; 19(9):844-5. PubMed ID: 22640746
[No Abstract] [Full Text] [Related]
18. Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
Moghanaki D; Freedland SJ; Anscher M
Int J Urol; 2013 May; 20(5):547-8. PubMed ID: 23094757
[No Abstract] [Full Text] [Related]
19. Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years.
Dörr M; Hölzel D; Schubert-Fritschle G; Engel J; Schlesinger-Raab A
Oncol Res Treat; 2015; 38(1-2):8-14. PubMed ID: 25633491
[TBL] [Abstract][Full Text] [Related]
20. Response to Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
Abdollah F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Int J Urol; 2013 May; 20(5):548-9. PubMed ID: 23278958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
